MGMT immunoexpression was assessed in a group of 45 SPAs of various histological subtypes, and the degree of expression (low expression defined as ≤50% immunostained adenoma cells and high as >50%) correlated with tumor aggressiveness. Here, MGMT is linked to neoplasm.